What does DENGIS B. Cabinet de Médecine do?

DENGIS B. Cabinet de Médecine is a general practice in Chaudfontaine. Private Limited, started on 22 June 2006, 1 establishment.

What is the address of DENGIS B. Cabinet de Médecine?

The registered office of DENGIS B. Cabinet de Médecine is located at Avenue Louis Piedboeuf 2, 4053 Chaudfontaine.

Is DENGIS B. Cabinet de Médecine still active?

Yes. According to the CBE (17 September 2026) DENGIS B. Cabinet de Médecine is active, legal situation “Normale toestand”, started on 22 June 2006.

Is DENGIS B. Cabinet de Médecine registered on Peppol?

No, DENGIS B. Cabinet de Médecine is currently not registered on the Peppol network.

What is the enterprise number of DENGIS B. Cabinet de Médecine?

The enterprise number of DENGIS B. Cabinet de Médecine is BE0882007736.

When was DENGIS B. Cabinet de Médecine founded?

DENGIS B. Cabinet de Médecine was founded on 22 June 2006.

Is DENGIS B. Cabinet de Médecine a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 June 2006; 4 annual accounts filed, latest fiscal year 2024.

How much profit did DENGIS B. Cabinet de Médecine make in 2024?

DENGIS B. Cabinet de Médecine posted a profit after taxes of € 29,428 in financial year 2024.

What is the revenue of DENGIS B. Cabinet de Médecine?

As a small company, DENGIS B. Cabinet de Médecine is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 81,266.

DENGIS B. Cabinet de Médecine (Private Limited)

Dossier DENGIS B. Cabinet de Médecine, printed on 17 September 2026 from databakkes.be/en/0882007736/dengis-b-cabinet-de-medecine. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

DENGIS B. Cabinet de Médecine from Chaudfontaine, company number BE0882007736, closed financial year 2024 with a result of € 29,428 after tax. For that financial year DENGIS B. Cabinet de Médecine recorded a gross margin of € 81,266 and equity of € 220,484. Compared with financial year 2023, the result moved from € 47,844 to € 29,428. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2025.

What it is worth Healthy

€ 220,484

▼ 45% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 29,428

▼ 38% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 480

▼ 98% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 208,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Vehicles and equipment

€ 7,085

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 186,735

▼ 3% vs 2023

€ 18,057 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 10,266

▲ 199% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,543

▲ € 12,205 vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 219,616 Gross margin 2021: € 219,616 First fiscal year in the series	€ 127,286 Gross margin 2022: € 127,286 ▼ 42% vs 2021 (€ 219,616) Unfavourable step	€ 108,281 Gross margin 2023: € 108,281 ▼ 15% vs 2022 (€ 127,286) Unfavourable step	€ 81,266 Gross margin 2024: € 81,266 ▼ 25% vs 2023 (€ 108,281) Unfavourable step	▼ 25%
Profit after taxes	€ 144,687 Profit after taxes 2021: € 144,687 First fiscal year in the series	€ 51,912 Profit after taxes 2022: € 51,912 ▼ 64% vs 2021 (€ 144,687) Unfavourable step	€ 47,844 Profit after taxes 2023: € 47,844 ▼ 8% vs 2022 (€ 51,912) Unfavourable step	€ 29,428 Profit after taxes 2024: € 29,428 ▼ 38% vs 2023 (€ 47,844) Unfavourable step	▼ 38%
Equity	€ 299,300 Equity 2021: € 299,300 First fiscal year in the series	€ 351,212 Equity 2022: € 351,212 ▲ 17% vs 2021 (€ 299,300) Favourable step	€ 399,056 Equity 2023: € 399,056 ▲ 14% vs 2022 (€ 351,212) Favourable step	€ 220,484 Equity 2024: € 220,484 ▼ 45% vs 2023 (€ 399,056) Unfavourable step	▼ 45%
Total debts	€ 142,780 Total debts 2021: € 142,780 First fiscal year in the series	€ 230,891 Total debts 2022: € 230,891 ▲ 62% vs 2021 (€ 142,780) Unfavourable step	€ 243,820 Total debts 2023: € 243,820 ▲ 6% vs 2022 (€ 230,891) Unfavourable step	€ 274,011 Total debts 2024: € 274,011 ▲ 12% vs 2023 (€ 243,820) Unfavourable step	▲ 12%
Cash	€ 35,688 Cash 2021: € 35,688 First fiscal year in the series	€ 37,266 Cash 2022: € 37,266 ▲ 4% vs 2021 (€ 35,688) Favourable step	€ 27,227 Cash 2023: € 27,227 ▼ 27% vs 2022 (€ 37,266) Unfavourable step	€ 480 Cash 2024: € 480 ▼ 98% vs 2023 (€ 27,227) Unfavourable step	▼ 98%
Land & buildings	€ 208,800 Land & buildings 2021: € 208,800 First fiscal year in the series	€ 324,212 Land & buildings 2022: € 324,212 ▲ 55% vs 2021 (€ 208,800) Unchanged	€ 304,971 Land & buildings 2023: € 304,971 ▼ 6% vs 2022 (€ 324,212) Unchanged	€ 285,729 Land & buildings 2024: € 285,729 ▼ 6% vs 2023 (€ 304,971) Unchanged	▼ 6%
Retained profit	€ 286,800 Retained profit 2021: € 286,800 First fiscal year in the series	€ 338,712 Retained profit 2022: € 338,712 ▲ 18% vs 2021 (€ 286,800) Favourable step	€ 386,556 Retained profit 2023: € 386,556 ▲ 14% vs 2022 (€ 338,712) Favourable step	€ 207,984 Retained profit 2024: € 207,984 ▼ 46% vs 2023 (€ 386,556) Unfavourable step	▼ 46%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 208,000 Dividend 2024: € 208,000 Unchanged (€ 0) Unchanged
Bank debt	€ 100,366 Bank debt 2021: € 100,366 First fiscal year in the series	€ 209,841 Bank debt 2022: € 209,841 ▲ 109% vs 2021 (€ 100,366) Unfavourable step	€ 193,054 Bank debt 2023: € 193,054 ▼ 8% vs 2022 (€ 209,841) Favourable step	€ 186,735 Bank debt 2024: € 186,735 ▼ 3% vs 2023 (€ 193,054) Favourable step	▼ 3%
Balance sheet total	€ 442,080 Balance sheet total 2021: € 442,080 First fiscal year in the series	€ 582,103 Balance sheet total 2022: € 582,103 ▲ 32% vs 2021 (€ 442,080) Unchanged	€ 642,876 Balance sheet total 2023: € 642,876 ▲ 10% vs 2022 (€ 582,103) Unchanged	€ 494,495 Balance sheet total 2024: € 494,495 ▼ 23% vs 2023 (€ 642,876) Unchanged	▼ 23%

Key figures of DENGIS B. Cabinet de Médecine, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 April 2026.

What happened to DENGIS B. Cabinet de Médecine?

What happened at DENGIS B. Cabinet de Médecine in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2025 New annual accounts for financial year 2024: profit of € 29,428 (▼ 38% vs 2023). Source: NBB ↗
Jun 22, 2006 Start of the company according to the CBE. KBO
Jun 9, 2006 New establishment in Liège. KBO

In short

From € 144,687 profit in 2021 to € 29,428 profit in 2024.

Paid € 102,831 in corporate taxes since 2021.

Best year ever: 2021, with € 144,687 profit.

Paid out € 208,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DENGIS B. Cabinet de Médecine? We notify you, reason included.

Follow DENGIS B. Cabinet de Médecine

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Louis Piedboeuf 2

4053 Chaudfontaine

2.366.000.145

Boulevard d'Avroy 192

4000 Liège

Active since 9 June 2006

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0882.007.736
VAT number: BE 0882.007.736
Registered office: Avenue Louis Piedboeuf 2, 4053 Chaudfontaine
Names & denominations: DENGIS B. Cabinet de Médecine · DENGIS BCM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 June 2006
Peppol: Not registered
Contact: [email protected] +3242322024
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

DENGIS B. Cabinet de Médecine